AXON Clinical Studies designs and delivers communication strategies that support recruitment, retention, and engagement across the full clinical trial lifecycle.
Successful studies depend on informed participants, confident site staff and communication that adapts as needs change. We use insight-led strategies to improve the study experience and help bring new therapeutic possibilities to life.
We identify participant and site communication needs, then create targeted plans to address recruitment barriers with clarity and care.
Through the right touchpoints at the right moments, we build connection with participants and site teams to support enrolment, retention and study momentum.
We design strategies that elevate representation, build trust and support studies that reflect the real-world populations they aim to serve.
We create meetings, training and resources that help site staff understand protocols, share best practice and stay motivated.
We use robust research methods to understand patient and site barriers, needs and motivations. These insights guide targeted strategies that recruit the right participants and support study completion.
We translate insight into clear, meaningful communication for participants, caregivers and families, supporting people throughout the study journey.
Committed site teams are central to timely study delivery. We create resources and touchpoints that give sites what they need, when they need it. Every study has its own barriers, people and momentum. Tell us what you are trying to achieve and we will help shape the right approach.
Find out more about some of the collaborations we are most proud of.
Engaging selected Investigators and Study Coordinators (Research Coordinator [RC]) in a meaningful dialogue on solutions to their colleagues and other site staff can help solve recruitment or retention gaps. Motivated RCs can also have a significant impact at the country level, with local knowledge and site-staff relationships.
READ MORE ›Identifying when, from where, how, and which format patients obtain information about their rare disease is a key factor in driving patient recruitment and retention. AXON was asked to develop a robust patient recruitment and retention program to support a Phase 3 study in a rare disease.
READ MORE ›Using TrialDiagnostic™, AXON revived the recruitment of a Phase 2 hypertension study that had fallen significantly behind with patient screening and enrollment. The negative perceptions of the study and medical device, due to failure of a related study, were addressed and reversed.
READ MORE ›